Viatris Inc. (VTRS)
NASDAQ
Real-time Data
01:30 PM
Day's Range
15.9852 wk Range
9.43Overview - VTRS - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
30.68B
P/E (Trailing)
‪235.80‬
P/E (Forward)
‪6.18‬
Price / Sales (TTM)
‪1.28‬
Price / Book
‪1.31‬
EV / EBITDA
‪7.14‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪-2.78%‬
Operating Margin
‪12.55%‬
Return on Assets
‪2.66%‬
Return on Equity
‪-2.75%‬
Ownership
Shares Outstanding
1.15B
Float
1.14B
Short % of Shares Outstanding
‪3.97%‬
Held by Insiders
‪0.31%‬
Held by Institutions
‪93.28%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪16.59‬
200-Day Avg
‪14.33‬
Dividends
Payout Ratio
‪960.00%‬
Frequency
Quarterly
Analyst Consensus
10 analysts
Average price target
‪$ 18.50‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - VTRS - Viatris Inc.
Peers - VTRS - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- VTRSNASDAQViatris Inc18.51BMarket Cap+33.89%52-week change235.80P/E (Trailing)‪-2.78%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences Inc.15.50BMarket Cap+12.18%52-week change22.34P/E (Trailing)‪20.91%‬Profit Margin
- ALALKSNASDAQAlkermes plc8.10BMarket Cap+40.00%52-week change127.18P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings, Inc.6.52BMarket Cap+43.82%52-week change23.92P/E (Trailing)‪17.69%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals Inc.6.23BMarket Cap+48.19%52-week change37.60P/E (Trailing)‪5.04%‬Profit Margin
- KNKNSANASDAQKiniksa Pharmaceuticals International, plc6.16BMarket Cap+58.19%52-week change79.83P/E (Trailing)‪9.59%‬Profit Margin
- ALMNASDAQAlmonty Industries Inc.5.33BMarket Cap+76.82%52-week change84.14P/E (Trailing)‪125.23%‬Profit Margin
Profile Summary - VTRS - Viatris Inc.
About
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongside globally recognized established brands such as Lipitor, Norvasc,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
